ARCHIVES

In Brief: Schepartz To Leave NCI for Academia; Woolley Names To Head Clinical Research At Lombardi

This article is from The Cancer Letter archive.

Vol. 10 No. 10 | March 9, 1984

Download PDF Visit The Full Archive

Related Articles

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

In Brief: NCI Seeks Better Ways to Make Available Fresh Tissue; Iverson Heads Cancer Control Science

October 5, 1984

FDA Approves Votrient For Soft Tissue Sarcomas

April 27, 2012

NCI-Approved Clinical Trials

November 24, 2006

Cancer Survival Now May Be Well Over 50 Percent, ACS President Says; Cigarette Consumption Drops

April 6, 1984

ACC Will Develop Standards, Patient Management Guidelines To Upgrade Community Cancer Programs

March 23, 1984